Intestinal dysbiosis: Novel mechanisms by which gut microbes trigger and prevent disease

Research output: Contribution to journalArticlepeer-review

39 Scopus citations


New research has identified specific intestinal colonizing microbes that can have significant influence on health and disease. Evidence is reviewed supporting an association between Fusobacterium nucleatum and colon cancer and for a protective role of Faecalibacterium prausnitzii in inflammatory bowel disease, of Escherichia coli Nissle 1917 in acute intestinal inflammation, of Bifidobacterium infantis in neonatal necrotizing enterocolitis, and of Akkermansia muciniphila in obesity and diabetes. These novel bacteria are clinically relevant and present opportunities for more focused diagnosis of colon cancer and prevention of common diseases.

Original languageEnglish (US)
Pages (from-to)133-137
Number of pages5
JournalPreventive Medicine
StatePublished - 2014


  • Acute intestinal inflammation
  • Akkermansia muciniphila
  • Bifidobacterium infantis
  • Colon cancer
  • Escherichia coli Nissle 1917
  • Faecalibacterium prausnitzii
  • Fusobacterium nucleatum
  • Inflammatory bowel disease
  • Necrotizing enterocolitis
  • Obesity

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Epidemiology


Dive into the research topics of 'Intestinal dysbiosis: Novel mechanisms by which gut microbes trigger and prevent disease'. Together they form a unique fingerprint.

Cite this